4um homepage
4um.com
News
Movies
Music
Medicine
Computers
Ireland
Cool Sites
Search


Click Here to return to the
 Tutorial Index Page

 


Hypertension and Anaesthesia

By Patrick Neligan, June 1998


All tutorials located on this site are the property of Patrick Neligan and are for personal study purposes only. They are not peer reviewed and no responsibility is taken for inaccuracies. These tutorials must not be reproduced without permission or used in any other publication.

Contents

  1. Clinical scenarios*
  2. What is hypertension? Classification of hypertension
  3. Why is hypertension important?
  4. Treatment of hypertension
  5. Pathophysiology of hypertension [pheripheral blood vessels]
  6. End organ damage (resulting from hypertension)
  7. Preoperative hypertension and perioperative risk
  8. Methods of reducing perioperative risk
  9. Acute Postoperative Hypertension
  10. Hypertensive emergencies
  11. Key points

*Solutions to these scenarios are not presented here at present. In reality there are no black and white answers. What really matters is that you have a rational and safe arguement for the decisions you take.


CLINICAL SCENARIOS


CASE 1

A 56 year old male presents for inguinal hernia repair. PMHx NAD. On no medications. On examination his BP is 190/110, and his ECG shows LVH with strain.

How would you manage this patient?


CASE 2

A 61 year old female undergoes an anterior resection for rectal carcinoma. She has known hypertension, treated with Amlodipine 5mg daily. In the recovery room postoperative, her blood pressure rises to 195/100.

How would you manage this patient?


CASE 3

A 79 year old female is admitted through A&E following a stroke. She has fallen down the stairs and has a subcapsular fracture of her right femur. On examination, she has a left hemiparesis. Her GCS score is 12. Her blood pressure is 220/120. She has bilateral papilloedema. The orthopaedic team are anxious to repair her hip to prevent fat embolism.

How would you manage this patient?


CASE 4

A 64 year old female, who is awaiting CABG, undergoes right carotid endarterectomy for a 90% occlusion. Her regular medications are isosorbide mononitrate 60 mg daily, diltiazem 90 mg bd, aspirin 75 mg daily and metoprolol 50 mg daily. You are called to see her in the high dependency unit. Her blood pressure is 200/90; her heart rate is 88.

How would you manage this patient?


CASE 5

A 33 year old female undergoes a laparoscopic cholecystectomy. Apart from her history of gallstones, her only other complaint is migraine. She has no known allergies. Family history is non contributory. In the anaesthetic room, her pulse was 110 and her BP was 110/60. Anaesthesia was induced with fentanyl, propofol and vecuronium. She has had morphine 10mg and cyclizine 25mg, and is expiring 1.3% isoflurane in 70% nitrous oxide.Twenty minutes after incision, her blood pressure suddenly rises to 210/110, and her heart rate increases to 150 beats/min.

How would you manage this patient?


WHAT IS HYPERTENSION?

Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure Arch Intern Med 153:154, 1993

Category

Systolic (mmHg)

Diastolic (mmHg)

Normal

<130

<85

High Normal

130 - 139

85 - 89

Hypertension

Stage 1 (mild)

140 - 159

90 - 99

Stage 2 (moderate)

160 - 179

100 - 109

Stage 3 (severe)

180 - 209

110 - 119

Stage 4 (very severe)

>210

>120

 

Diagnosis of hypertension (HTN) is made when two or more readings (on different visits), of diastolic blood pressure (BP) >90 mmHg, or systolic BP >140 mmHg.

Isolated systolic hypertension: SBP > 140 mmHg, DBP <90 mmHg.

Essential hypertension: no cause can be found (95% of cases).

Accelerated hypertension: markedly elevated HTN plus grade 3 retinopathy (haemorrhages and exudates).

Malignant hypertension: markedly elevated HTN (diastolic>140mmHg) plus papilloedema.

Complicated hypertension: HTN plus cardiovascular ("end organ") damage consequent to it: stroke, CCF, renal failure, MI, AAA.

White coat hypertension: BP only raised when examined by a health care professional.

 


CLASSIFICATION

Primary ["Essential"] hypertension.

Secondary hypertension:

A) Systolic hypertension with wide pulse pressure:
  • Aortic regurgitation
  • Thyrotoxicosis
  • Patent ductus arteriosus
B) Systolic and diastolic hypertension with increased PVR

1. Renal

  • Glomerulonephritis (acute or chronic)
  • Pyelonephritis
  • Polycystic kidneys
  • Renal artery stenosis
  • Polycystic kidneys

2. Endocrine

  • Cushing’s syndrome (excessive glucocorticoids)
  • Congential adrenal hyperplasia
  • Conn’s syndrome (primary hyperaldosteronism)
  • Phaeochromocytoma
  • Hypothyroidism
  • Acromegaly

3. Neurogenic

  • Raised intracranial pressure
  • Psychological ("white coat hypertension")
  • Acute porphyria
  • Lead poisoning

4. Miscellaneous

  • Coarctation of the aorta
  • Polyarteritis Nodosa
  • Hypercalcaemia
  • Increased intravascular volume (PRV)

 


WHY IS HYPERTENSION IMPORTANT?

  1. It is common (50 million Americans).
  2. It is a risk factor for cardiovascular disease.
  3. It causes end organ damage: heart, brain, kidneys
  4. It may indicate the presence serious endocrine related disese: diabetes, thyrotoxicosis, phaeochromocytoma, Cushing’s, Conn’s, etc.
  5. It may indicate the presence of serious renal disease.
  6. It increases the risk of an adverse anaesthetic outcome.
  7. Perioperatively it indicates:
Anxiety
Inadequate anaesthesia [awareness]
Inadequate analgesia.

TREATMENT OF HYPERTENSION

Diuretics

  1. Thiazide diuretics – reduce blood volume and vasodilate
  2. Loop diuretics – much less effective

 


Sympathoplegics

1. Receptors: Beta blockers – reduce cardiac output initially, later ¯ PVR

Alpha blockers – useful in diabetics or as second line tx

2. CNS active agents: Methyldopa and clonidine, a 2 selective, decrease sympathetic outflow [mechanism unknown]. Salt retention. Rebound HTN.

3. Ganglion blockers: block sympathetic ganglia. Cause postural hypotension.

4. Post ganglionic sympathetic nerve terminal blockers. Drugs that deplete nerve terminal of NAD stores (reserpine), block release of NAD (guanethidine).

 


Vasodilators

1. Nitroprusside – vasodilatation secondary to nitric oxide activity.

2. Hydralazine – action unknown, acts on arterioles.

3. Calcium channel blockers – nifedipine, diltiazem, amlodopine.

4. Nitrates – vasodilation secondary to release of nitric oxide, dilate veins>arteries>arterioles.

 


Angiotensin Antagonists

Angiotensin converting enzyme inhibitors antagonise the conversion of Angiotensin I to Angiotensin II, and the metabolism of bradykinin. Angiotensin is a vasoconstrictor, which stimulated the release of aldosterone (conserves salt and water in the kidney). Bradykinin a vasodilator.

 


Others

Magnesium acts as a calcium channel blocker, thus vasodilating.

 


TREATMENT PROTOCOLS

Non urgent: Beta blocker +/- thiazide, or calcium channel blocker (asthmatics) or ACE inhibitor (diabetes / associated CCF).

Urgent: GTN, then nitroprusside or labetolol, then hydralazine. "Bring the BP down gently"

 


PATHOPHYSIOLOGY OF ESSENTIAL HYPERTENSION


PERIPHERAL BLOOD VESSELS

  1. The arterial and arteriolar walls are thickened.
  2. There is a high ratio of wall thickness to internal diameter.
  3. Vascular contraction leads to an abnormally large increase in blood pressure
  4. There is relative hypovolaemia (reduced intravascular volume).
  5. Vascular relaxation leads to a greater than expected decrease in blood pressure.
  6. Additionally, vascular relaxation unmasks the relative hypovolaemic state.
  7. Rehydration following relaxation causes rebound hypertension when the status quo returns

 


END ORGAN DYSFUNCTION


1. THE HEART

ECG shows left ventricular hypertrophy with strain

BP = CO X PR

PERIPHERAL RESISTANCE (PR): circulating blood volume, vascular tone (smooth muscle and local vasoactive agents) sympathetic nervous system activity, renin-angiotensin – aldosterone axis, antidiuretic hormone, atrial natiuretic peptide.

CARDIAC OUTPUT

CO = HR X SV

HEART RATE: depends on baroreceptor activity, sympathetic nervous system activity and vagal tone

STROKE VOLUME depends on Preload (LVEDV), Afterload (LV systolic wall tension and peripheral resistance), and contractility (Starling curve).

WALL TENSION: Laplace’s Law:

Wall tension = transmural pressure X ventricular radius / 2 X wall thickness

In order to cope with the increased afterload, the heart hypertrophies [increasing the denominator above]. This leads to increased myocardial O2 requirement, and endomyocardial fibrosis. Cardiac dilatation eventually follows, and subsequent heart failure.

Hypertension causes:

  1. Acceleration of atheromatous disease.
  2. Myocardial ischaemia in the absence of coronary artery disease.
  3. Decreased myocardial compliance and an increase in the atrial contribution to diastolic filling and cardiac output.
  4. Congestive cardiac failure / pulmonary oedema.

Fleisher and Barash: Anaesthesia and Analgesia 1992 74; 586 – 598

"The risk for perioperative myocardial ischaemia is increased in hypertensive patients with left ventricular hypertrophy."

 


2. BRAIN

  • Chronic Hypertension causes a shift to the right in cerebral and renal autoregulation
  • Decreases in cerebral blood flow and cerebral ischaemia occur at higher blood pressures than in normotensive patients.
  • Long term therapy: autoregulation curve shifts leftward normal.

Strandgaard S: Circulation 1976 53:720-27

Autoregulation of cerebral blood flow in hypertensive patients.

Lower limit of autoregulation was:

113mmHg in severe hypertension 73 mmHg in normotensive patients

Lowest limit of blood pressure tolerated without symptoms was:

65 mmHg in severe HTN, 53 mmHg in treated HTN, 43mmHg in normotensives

This return to the right occurs after 8 – 12 months, maybe longer.

Clinical Pearl

We cannot measure cerebral autoregulation, so a good rule of thumb is:

  • A 25% decrease in MAP reaches the lower limit of autoregulation.
  • A 55% decrease in MAP reaches symptomatic brain hypoperfusion.
  • Remember that these patients may also have cerebrovascular and carotid arterial disease. "Watershed" ischaemia may occur with even relative hypoperfusion.
  • Treatment of hypertension significantly reduces the incidence of stroke.

 


3. RENAL

  • Chronic hypertension affects renal autoregulation in the same way as the brain.

The kidneys are "sitting ducks" in hypertension.

  • End organ damage to the kidneys from HTN: glomerular sclerosis, abnormal distribution of renal blood flow & decreased GFR.

"Prerenal" hypoperfusion due to a sudden and sustained decrease in BP (during anaesthesia for major surgery) leads to postoperative renal insufficiency.

 


PREOPERATIVE HYPERTENSION AND PERIOPERATIVE RISK


Determinants of risk:

  • Level of blood pressure.
  • Duration of treatment.
  • Degree of end organ damage.
  • Type of surgery.

Level of hypertension:

From Wolfstal SD MCNM 1993, Prys-Roberts BJA 1974, Charlson SGO 1991

  • Severe HTN increased risk: BP lability, myocardial ischaemia, MI, pulmonary oedema arrhythmias, renal failure and neurologic damage.

From Goldman and Caldera Anesthesiology 1979

  • Patients with mild to moderate hypertension are not at increased risk of major morbid events.
  • Patients with any form of preoperative hypertension, treated or untreated, have an increased risk of post op HTN.
  • Prolonged increases or decreases in MAP by 20 mmHg or 20% increased risk of postoperative complications.

 


The Bottom Line

  • Asymptomatic patients with mild to moderate HTN (DBP<110 mmHg) are not at increased risk.
  • The presence of severe end-organ damage (LVH, CRF, CVA, CAD, LVF) increases the risk significantly.
  • Elective surgery should be postponed in the case of DBP>110 mmHg + complications, DBP>120 mmHg without.
  • Isolated systolic HTN <200 mmHg should not defer surgery unless for vascular surgery or craniotomies (increased risk).

Type of surgery associated with increased risk:

Aortic surgery, carotid endarterectomy, CABG, craniotomies (aneurysm clipping), AVM, posterior fossa surgery. All at risk of postop HTN (Goldman).

 


METHODS TO REDUCE PERIOPERATIVE RISK

1. Adequate preoperative blood pressure control.

Continue all antihypertensives up to and including the day of surgery (except diuretics).

Delay elective surgery if SBP>200 mmHg, or if DBP >120 mmHg, until BP <190/110 mmHg, preferably lowered to 140/90 mmHg over several weeks.

Acute control within hours of surgery is inadvisable.

 


2. Antihypertensive therapy

Use of agents to attenuate the haemodynamic responses to intubation, incision and extubation:

  • Opioids – Fentanyl, Alfentanyl.
  • Antihypertensives – Esmolol, Labetalol, Atenolol, Metoprolol, clonidine, enalapril (one dose preop).
  • Lignocaine

 


3. Hydration

Volume load the hypertensive patient prior to induction.

This helps to minimise the peaks and valleys that characterise the hypertensive patient.

 


4. Choice of agents

Consider using agents with minimal haemodynamic effects – fentanyl, thiopentone rather than propofol, pethidine rather than morphine, vecuronium or cis-atracurium rather than atracurium, sevoflurane induction etc.

 


5. Analgesia

Opioid and non steroidal anti-inflammatory agents prevent the hypertensive response to pain, intra- and post- operatively.

 


ACUTE POSTOPERATIVE HYPERTENSION

Differential diagnosis

  • Pain
  • Emergence excitement
  • Hypercarbia
  • Intolerance of endotracheal tube
  • Full bladder
  • Hypervolaemia
  • Hypothermia
  • Withdrawl of chronic therapy

Risk associated:

  • Loss of vascular anastomoses
  • Intracranial bleeding
  • Myocardial ischaemia [particularly when associated with tachycardia]

 


Treatment

Depends on

  • The clinical situation
  • The aetiology
  • The degree of hypertension
  • Analgesia must be optimized
  • Hypertension, where worrisome, should be treated with: GTN, Labetolol, Esmolol, Nitroprusside, Hydralazine etc. Avoid sublingual nifedipine.

 


Hypertensive Emergencies

Malignant Hypertension is defined as:
A syndrome characterised by hypertension 
accompanied by an encephalopathy or nephropathy
Common Causes of Hypertensive Crises 	
  • Antihypertensive drug withdrawal (e.g., clonidine)
  • Autonomic hyperactivity
  • Collagen-vascular diseases Drugs (e.g., cocaine, amphetamines)
  • Glomerulonephritis (acute)
  • Head trauma
  • Neoplasias (e.g., pheochromocytoma)
  • Preeclampsia & eclampsia
  • Renovascular hypertension

 


Pathophysiology

  1. Abrupt increases in systemic vascular resistance likely related to humoral vasoconstrictors.
  2. Endothelial injury
  3. Fibrinoid necrosis of the arterioles
  4. Deposition of platelets and fibrin
  5. Breakdown of the normal autoregulatory function.
  6. The resulting ischemia prompts further release of vasoactive substances completing a vicious cycle

 


CLINICAL MANIFESTATIONS

The manifestations of hypertensive crises are those of end-organ dysfunction:

  1. Hypertensive encephalopathy
  2. Acute aortic dissection
  3. Acute myocardial infarction
  4. Acute cerebral vascular accident
  5. Acute hypertensive renal injury
  6. Acute congestive heart failure

It is important to recognize that the absolute level of BP may not be as important as the rate of increase. Patients with longstanding hypertension may tolerate systolic BPs of 200 mm Hg or diastolic BPs of up to 150 mm Hg without developing hypertensive encephalopathy, while children or pregnant women may develop encephalopathy with diastolic BPs 100 mm Hg.


Hypertensive encephalopathy:

  • Headache
  • Altered level of consciousness and confusion.
  • Acute CVA with intraventricular bleeding or ischemic infarction may result in focal neurological abnormalities.
  • Fundoscopy: advanced retinopathy with arteriolar changes, hemorrhages,exudates, papilloedema.

Cardiovascular manifestations:

  • Angina
  • LVF
  • Acute myocardial infarction.
  •  

Aortic dissection.

  • Propagation of the dissection is dependent not only on the elevation of the blood pressure itself, but also on the velocity of left ventricular ejection.

Renal Manifestations:

  • Renal failure with oliguria and/or hematuria.

 


Management

The key to is the prompt recognition and initiation of treatment.

  • What was the patient's blood pressure prior to presentation, does the patient have any prior or current complaints, and what medications, prescription and nonprescription, has the patient taken?
  • Palpation of pulses in all extremities is necessary.
  • A fundoscopic examination is mandatory
  • FBC, urea, creatinine, urinalysis, chest x-ray, electrocardiogram (and head computed tomography are useful in patients with evidence of shortness of breath, chest pain, or neurological changes, respectively).
  • These tests are performed simultaneously with the initiation of antihypertensive therapy.

 


Sodium Nitroprusside

  • Sodium nitroprusside is a combined arterial and venous vasodilator that decreases both the afterload and preload.
  • It is a very potent agent.
  • The onset of action of this drug is within seconds, with a duration of action of one-to-two minutes and a plasma half-life of three to four minutes.
  • Continuous BP measurement is recommended.If the infusion is stopped, the BP begins to rise immediately and returns to the pre-treatment level within one to ten minutes.
  • Sodium nitroprusside is metabolized into cyanogen, which is converted into thiocyanate by the enzyme thiosulfate sulfurtransferase.Therefore, cyanide poisoning may occur with prolonged intravenous administration of sodium nitroprusside. Consider this diagnosis in patients who develop central nervous system depression, seizures, lactic acidosis and/or cardiovascular instability.The toxicity of sodium nitroprusside usually occurs after several days of infusion however, it may occur within the first 24 hours with high dose administration.

 


Calcium Channel Blockers: Nifedipine

  • Nifedipine is not absorbed through the buccal mucosa, and the common order for administration sublingually should be changed to bite and swallow.
  • Nifedipine causes direct vasodilatation of arterioles reducing peripheral vascular resistance promptly.
  • The onset of action begins within 15 minutes of oral administration and peaks at 30 minutes.
  • The duration of action may be four to six hours.
  • Sudden reductions in BP accompanying administration of nifedipine may precipitate ischemic events.
  • Nifedipine also produces reflex tachycardia, which in turn, in patients with preexisting coronary artery disease may induce myocardial ischemia.

 


Labetalol

  • Labetalol is a combined blocker of the alpha and beta adrenergic receptors.
  • When given intravenously, labetalol produces a prompt and controlled reduction in BP in patients with hypertensive crises.
  • The effects of this drug begin five minutes after administration, and may last for at least four to six hours.
  • The rapid fall in BP results from a decrease in peripheral vascular resistance and a slight fall in cardiac output.
  • One of the advantages of this drug is that it is also effective as an oral antihypertensive agent and once the initial parenteral treatment has been established, it can be followed with oral administration.

 


Esmolol

  • Esmolol is a beta-adrenergic blocking agent that has an extremely brief elimination half-life (<10 minutes). This agent is available for intravenous use both as a bolus and as an infusion.

KEY POINTS IN HYPERTENSION

  • Hypertension is conventionally considered a BP of >160/90,isolated SystolicHTN is age +130
  • Hypertension causes cardiovascular, renal, and cerebrovascular disease. Treatment significantly lowers the risk.
  • 95% of cases are "Primary". Causes of secondary HTN are renal, endocrine or neurogenic in origin.
  • Hypertension causes thickening of arterial walls, an increased wall thickness to lumen size ratio and relative hypovolaemia.. Larygoscopy causes a greater than expected increase in BP and induction unmasks relative hypovolaemia: "roller coaster"
  • Hypertension causes LVH, CCF& myocardial ischaemia.
  • Renal and brain autoregulation is reset at a higher level, the lower limit of autoregulation is a 25% decrease in MAP. A 55% decrease causes symptomatic brain hypoperfusion.
  • Anaesthesia can therefore precipitate myocardial, cerebral and renal ischaemia.
  • Perioperative risk depends on the level of BP, duration of treatment, degree of end organ damage, type of surgery.
  • Vascular and neurosurgery are associated with higher risk.
  • Elective surgery should be delayed in patients presenting with DBP>110 with end organ damage, DBP>120 without.
  • Prolonged increases or decreases in MAP by 20mmHg increases the risk of perioperative complications.
  • Preoperative risk is minimised by continuing pre op medications, pre induction hydration and the use of analgesics and other agents to reduce the haemodynamic responses to intubation, surgery and extubation.
  • Post op hypertension is assessed depending on the degree of HTN, the clinical scenario and the aetiology of the HTN.
  • Hypertensive emergencies include encephalopathy, stroke, dissecting aneurysm and phaeochromocytoma. Treatment is most effective with nitrates, nitroprusside, beta blockers and hydralazine. Invasive monitoring is essential.

Top of Page
4um.com

Copyright 1999 4um.com, owned and operated by Pat Neligan